referring to webmd
DNA-Based Vaccine Guards Against Zika in Monkey Study
DNA-Based Vaccine Guards Against Zika in Monkey Study
Vaccine Guards Against Zika in Monkey StudyHuman safety trials are already under way, researchers addWebMD News from HealthDayBy Dennis ThompsonHealthDay ReporterTHURSDAY, Sept. 22, 2016 (HealthDay News) -- An experimental DNA-based vaccine protected monkeys from infection with the birth defects-causing Zika virus, and it has proceeded to human safety trials, researchers report."The vaccine universally elicited antibodies from all primates, but for the animals that got a full dose of vaccine, 17 of 18 were protected from infection," said study co-author Ted Pierson.He is chief of the Viral Pathogenesis Section at the U.S. National Institute of Allergy and Infectious Diseases.
not to mention hcplive
US Funds Zika Vaccine as Cases Mount
US Funds Zika Vaccine as Cases Mount
US Funds Zika Vaccine as Cases MountAs Zika concerns mount in the US, the federal government has agreed to fund a second drug company's quest to develop a vaccine to prevent Zika infection.Sanofi Pasteur will get $43.18 million in funding from the US Health and Human Service's Biomedical Advanced Research and Development Authority (BARDA), money to be used for phase 2 trials once the vaccine is ready.That is expected to be in 2018.The vaccine uses purified inactivated virus (ZPIV)Phase 1 trials have already begun.
by the same token on jamanetwork
Zika Vaccine Enters Clinical Trials
Zika Vaccine Enters Clinical Trials
Also Meets CME requirements for:Accreditation InformationThe American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course.Physicians should claim only the credit commensurate with the extent of their participation in the activity.
No comments:
Post a Comment